Donanemab Clinical Trials

1 actively recruiting trial across 1 location

▼ -1 trial since May 2026

Also known as: (LY3002813), LY3002813

Top Sponsors

Eli Lilly and Company1

Indications

Alzheimer's Disease1
Alzheimer Disease1

Huntsville, Alabama1 trial

A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease

Rehabilitation & Neurological Services

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.